Challenges in Preventing Bone Loss Induced by Aromatase Inhibitors

Abstract Context: Aromatase inhibitors have become a mainstay in the adjuvant treatment regimen in postmenopausal women with hormone receptor–positive breast cancer. While many of these patients have an excellent long-term prognosis, adverse effects on bone represent an emerging complication of arom...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of clinical endocrinology and metabolism 2020-10, Vol.105 (10), p.3122-3133
Hauptverfasser:	Rachner, Tilman D, Göbel, Andy, Jaschke, Nikolai P, Hofbauer, Lorenz C
Format:	Artikel
Sprache:	eng
Schlagworte:	Aromatase Aromatase Inhibitors - adverse effects Bisphosphonates Bone Density - drug effects Bone Density Conservation Agents - therapeutic use Bone loss Bone strength Breast cancer Breast Neoplasms - drug therapy Denosumab - therapeutic use Diphosphonates - therapeutic use Drug therapy Female Fractures Humans Monoclonal antibodies Mushrooms Osteoporosis Osteoporosis - chemically induced Osteoporosis - prevention & control Post-menopause Prevention Risk factors Targeted cancer therapy TRANCE protein
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!